A 10-day dual regimen of vonoprazan and amoxicillin is noninferior to bismuth quadruple therapy for Helicobacter pylori ...
1. Moss SF. The clinical evidence linking Helicobacter pylori to gastric cancer. Cell Mol Gastroenterol Hepatol. 2016;3(2):183-191. doi:10.1016/j.jcmgh.2016.12.001 2 ...
New insights into how the cancer-causing stomach bacterium keeps its shape could point the way for future, more-specialized antibiotics One of H. pylori’s defining characteristics is right there in ...
Last month, the Food and Drug Administration (FDA) approved Voquenza Dual (vonoprazan fumarate + amoxicillin) and Triple Paks (vonoprazan fumarate + amoxicillin + clarithromycin) for the treatment of ...
A strain of probiotic bacteria that may help treat ulcers caused by Helicobacter pylori has been identified by Spanish scientists, according to an article published in Applied and Environmental ...
Morning Overview on MSN
This stealthy bacteria could trigger millions of cancer cases worldwide
A bacterium that infects roughly half the world’s population, often without producing symptoms for decades, may be responsible for the vast majority of stomach cancer cases projected to occur in the ...
The findings of a new study suggest a possible association between H. pylori infection and the pathophysiology of vitiligo. Based on this link, H. pylori eradication therapy may serve as ...
Helicobacter pylori is a Gram-negative bacterium commonly found in the gastric epithelium. Infection of the gastrointestinal tract by Helicobacter pylori results in gastritis, peptic ulcer, and ...
(Medical Xpress) -- The debate over the bacteria Helicobacter pylori continues as a new study published in Clinical Infectious Diseases shows that people carrying H. pylori have a reduced risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results